Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
lymphatic diseases
MeSH D008206 - lymphatic diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006425:
Hemic and lymphatic diseases
1 Company
1 Drug
$
Success rate
D008206:
Lymphatic diseases
0 Companies
0 Drugs
Success rate
D000072281:
Lymphadenopathy
0 Companies
0 Drugs
Success rate
D008199:
Lymphadenitis
0 Companies
0 Drugs
Success rate
D008200:
Lymphangiectasis
0 Companies
0 Drugs
Success rate
D008205:
Lymphangitis
0 Companies
0 Drugs
Success rate
D008209:
Lymphedema
0 Companies
0 Drugs
Success rate
D008210:
Lymphocele
0 Companies
0 Drugs
Success rate
D008232:
Lymphoproliferative disorders
2 Companies
2 Drugs
$
Success rate
D009080:
Mucocutaneous lymph node syndrome
3 Companies
1 Drug
$
Success rate
D013158:
Splenic diseases
1 Company
1 Drug
$
Success rate
D013952:
Thymus hyperplasia
0 Companies
0 Drugs
Success rate
D013953:
Thymus neoplasms
0 Companies
0 Drugs
Success rate
D015614:
Histiocytosis
16 Companies
2 Drugs
$
Success rate
D019310:
Pseudolymphoma
0 Companies
0 Drugs
Success rate
D044148:
Lymphatic abnormalities
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
20
%
1/5
Phase 2
0
%
0/5
Phase 3
0
%
0/0
Approved:
0
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use